Radiology News

ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR) announced today that it will release financial results for third quarter 2026 after market close on Tuesday, October 27, 2026. Following the news release, the company will host a conference call the next day, Wednesday, October 28, 2026, at 10:00 am ET to discuss the results. A live webcast and the subsequent replay will be available at https://mirion-3q-2026.open-exchange.net. About Mirion Mirion (NYSE: MIR) is a global leader in radiation safety, s...

IRVING, Texas--(BUSINESS WIRE)--The event featured congressional staff, stakeholders and health system executives’ perspectives on the innovations changing hospital care delivery....

WALTHAM, Mass.--(BUSINESS WIRE)--CellTivity Scientific, a leader in point-of-care tissue assessment, announced that its Van Gogh Microscopy System has now been utilized in more than 10,000 patient procedures, marking an important milestone as adoption of the company’s Dynamic Cell Imaging™ technology continues to grow in the U.S. and internationally.CellTivity’s Van Gogh Microscopy System provides metabolic cellular imaging designed to support timely, intraprocedural tissue assessment and decisi...

BELOIT, Wis.--(BUSINESS WIRE)--NorthStar Medical Technologies, LLC (NorthStar), the first commercial-scale producer of no-carrier-added actinium-225 (n.c.a. Ac-225) using electron-accelerator technology, today announced a strategic partnership with Quarkmed, a Beijing-based contract research organization (CRO) specializing in nuclear medicine and radiopharmaceutical clinical development, with expertise spanning pharmaceutical regulatory affairs, clinical development, and clinical trial operatio...

CANTON, Ohio--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading nonprofit breast cancer organization, today joined Rep. Emilia Sykes, Northeast Ohio breast cancer advocates and Cleveland Clinic Mercy Hospital Cancer Center leaders for a community roundtable focused on improving access to timely breast cancer imaging for patients across Ohio. More than 11,000 people in Ohio will be diagnosed with breast cancer in 2026 and more than 1,500 will die from the disease this year alone.The roundtabl...

SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA-PME eligible, "Median" or the "Company"), developer of eyonis®, a suite of artificial intelligence (AI) powered Software as Medical Devices (SaMD) for early cancer detection and diagnosis, and a globally leading provider of AI-based image analyses and central imaging services for oncology drug developers, today announced that eyonis Inc., its U.S. subsidiary, will participate in the CHEST 2...

SEATTLE--(BUSINESS WIRE)--Curi Bio Expands the Curiverse™ with New Disease Models, Casting Kits, and Application-Ready Solutions...

MIAMI & BALTIMORE--(BUSINESS WIRE)--OpenEvidence and Johns Hopkins Medicine are collaborating to design medical education and clinical care for the AI era, with patients at the center....

BURLINGTON, Mass. & BLACKSBURG, Va.--(BUSINESS WIRE)--The Edward Via College of Osteopathic Medicine (VCOM) and Butterfly Network, Inc. (NYSE: BFLY), a pioneer and leader in semiconductor-based ultrasound devices, cloud software and AI, today announced a long-term alliance and joint investment in establishing VCOM and its students as a center of excellence for ultrasound education and community care. The first-of-its-kind program combines one-probe-per-student deployment, integrated education a...

SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies to present positive data on new test under development to measure lung inflammation in asthma and COPD at CHEST 2026...